| | | | | |
BDSX Biodesix, Inc. Common Stock | €19,4157 | +10,32 % | €198,89M | €68,67K | |
IRAB Iris Acquisition Corp II | €8,7341 | +0,50 % | €198,84M | €15,72 | |
REFI Chicago Atlantic Real Estate Finance, Inc. Common Stock | €9,3192 | -0,09 % | €198,81M | €127,56K | |
SMTI Sanara MedTech Inc. Common Stock | €20,7957 | -1,73 % | €198,81M | €57,19K | |
SABA Saba Capital Income & Opportunities Fund II | €7,1619 | -0,73 % | €198,74M | €145,80K | |
CRAC Crown Reserve Acquisition Corp. I Class A Ordinary Shares | €8,8257 | -0,25 % | €197,51M | €10,87K | |
NPV Nuveen Virginia Quality Municipal Income Fund | €10,0004 | +0,18 % | €197,00M | €119,12K | |
OPBK OP Bancorp Common Stock | €12,8171 | +0,93 % | €196,95M | €4,72K | |
PNNT Pennant Investment Corp | €2,9772 | +0,85 % | €196,75M | €430,67K | |
AOMR Angel Oak Mortgage REIT, Inc. | €7,7733 | +0,23 % | €196,71M | €35,09K | |
| €2,2359 | -1,54 % | €196,09M | €176,48K | |
| €5,6858 | -2,69 % | €196,00M | €495,05K | |
CHRS Coherus Oncology, Inc. Common Stock | €1,4149 | -1,82 % | €195,34M | €254,28K | |
KROS Keros Therapeutics, Inc. Common Stock | €10,4808 | +2,83 % | €194,64M | €244,42K | |
QTTB Q32 Bio Inc. Common Stock | €10,9524 | -10,90 % | €193,85M | €207,05K | |
